Cited 63 times in
Analysis of overall survival from a phase III study of ixabepilone plus capecitabine versus capecitabine in patients with MBC resistant to anthracyclines and taxanes
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.